Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers

Chemical Research in Toxicology

Volumn 22, Issue 4, 2009, Pages 734-741

  Carmella, Steven G ^a   Chen, Menglan ^a   Han, Shaomei ^a   Briggs, Anna ^a   Jensen, Joni ^a   Hatsukami, Dorothy K ^a   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(N ACETYLCYSTEINYL)BENZENE; (N ACETYLCYSTEINYL)ETHANOL; 1 (N ACETYLCYSTEINYL) 2 HYDROXY 3 BUTENE; 1 (N ACETYLCYSTEINYL)PROPAN 3 OL; 1 HYDROXY 2 (N ACETYLCYSTEINYL) 3 BUTENE; 1 HYDROXYPYRENE; 1,2 DIHYDROXY 4 (N ACETYLCYSTEINYL)BUTANE; 1,3 BUTADIENE; 2 (N ACETYLCYSTEINYL)BUTAN 4 OL; 2 HYDROXYETHYL MERCAPTURIC ACID; 3 HYDROXYPROPYL MERCAPTURIC ACID; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 HYDROXYBUT 2 YL MERCAPTURIC ACID; ACETYLCYSTEINE DERIVATIVE; ACROLEIN; BENZENE; CARCINOGEN; CIGARETTE SMOKE; CROTONALDEHYDE; DIHYDROXYBUTYL MERCAPTURIC ACID; ETHYLENE OXIDE; MONOHYDROXYBUTYL MERCAPTURIC ACID; PHENYL MERCAPTURIC ACID; POLYCYCLIC AROMATIC HYDROCARBON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; REDUCTION; SMOKING CESSATION; SOLID PHASE EXTRACTION;

ACETYLCYSTEINE; BIOLOGICAL MARKERS; CARCINOGENS; CHROMATOGRAPHY, LIQUID; HUMANS; SMOKING; SMOKING CESSATION; TANDEM MASS SPECTROMETRY; TIME FACTORS;

NICOTIANA TABACUM;

EID: 66049088370     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx800479s     Document Type: Article

References (66)

1. International Agency for Research on Cancer. (2004) Tobacco Smoke and Involuntary Smoking. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.83, pp 33-1187, IARC, Lyon, France.
2. Spitz, M. R., Etzel, C. J., Dong, Q., Amos, C. I., Wei, Q., Wu, X., and Hong, W. K. (2008) An expanded risk prediction model for lung cancer. Cancer Prev. Res. 1, 250-254.
3. Hatsukami, D. K., Benowitz, N. L., Rennard, S. I., Oncken, C., and Hecht, S. S. (2006) Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob. Res. 8, 600-622. (Pubitemid 43675073)
4. Scherer, G., Urban, M., Engl, J., Hagedorn, H. W., and Riedel, K. (2006) Influence of smoking charcoal filter tipped cigarettes on various biomarkers of exposure. Inhal. Toxicol. 18, 821-829. (Pubitemid 43916876)
5. Sapkota, A., Halden, R. U., Dominici, F., Groopman, J. D., and Buckley, T. J. (2006) Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry. Chem.-Biol. Interact. 160, 70-79. (Pubitemid 43227483)
6. Carmella, S. G., Chen, M., Zhang, Y., Zhang, S., Hatsukami, D. K., and Hecht, S. S. (2007) Quantitation of acrolein-derived 3-hydroxyl- propylmercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry: effects of cigarette smoking. Chem. Res. Toxicol. 20, 986-990. (Pubitemid 47204811)
7. Scherer, G., Urban, M., Hagedorn, H. W., Feng, S., Kinser, R. D., Sarkar, M., Liang, Q., and Roethig, H. J. (2007) Determination of two mercapturic acids related to crotonaldehyde in human urine: influence of smoking. Hum Exp Toxicol. 26, 37-47. (Pubitemid 46262745)
8. Scherer, G., Engl, J., Urban, M., Gilch, G., Janket, D., and Riedel, K. (2007) Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul. Toxicol. Pharmacol. 47, 171-183. (Pubitemid 46209369)
9. Calafat, A. M., Barr, D. B., Pirkle, J. L., and Ashley, D. L. (1999) Reference range concentrations of N-acetyl-S-(2-hydroxyethyl)-L-cysteine, a common metabolite of several volatile organic compounds, in the urine of adults in the United States. J. Expo. Anal. Environ. Epidemiol. 9, 336-342. (Pubitemid 29416587)
10. Hecht, S. S. (2002) Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23, 907-922. (Pubitemid 34752946)
11. Roemer, E., Stabbert, R., Rustemeier, K., Veltel, D. J., Meisgen, T. J., Reininghaus, W., Carchman, R. A., Gaworski, C. L., and Podraza, K. F. (2004) Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195, 31-52. (Pubitemid 38036981)
12. International Agency for Research on Cancer. (2009) In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.97, IARC, Lyon, France, in press.
13. Kensler, C. J., and Battista, S. P. (1963) Components of cigarette smoke with ciliary-depressant activity. Their selective removal by filters containing activated charcoal granules. N. Engl. J. Med. 269, 1161-1166.
14. Feng, Z., Hu, W., Hu, Y., and Tang, M. S. (2006) Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. U.S.A. 103, 15404-15409. (Pubitemid 44625604)
15. Counts, M. E., Hsu, F. S., Laffoon, S. W., Dwyer, R. W., and Cox, R. H. (2004) Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. Regul. Toxicol. Pharmacol. 39, 111-134. (Pubitemid 38388196)
16. International Agency for Research on Cancer. (1995) Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.63, pp 373-391, IARC, Lyon, France.
17. International Agency for Research on Cancer. (1994) Some Industrial Chemicals. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol.60, pp 73-159, IARC, Lyon, France.
18. International Agency for Research on Cancer. (1982) Some Industrial Chemicals and Dyestuffs. In IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol.29, pp 93-148, IARC, Lyon, France.
19. International Agency for Research on Cancer. (2007) Smokeless Tobacco and Tobacco-Specific Nitrosamines. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol.89, pp 548-553, IARC, Lyon, France.
20. Straif, K., Baan, R., Grosse, Y., Secretan, B., El Ghissassi, F., and Cogliano, V. (2005) Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol. 6, 931-932. (Pubitemid 41685225)
21. Elfarra, A. A., Sharer, J. E., and Duescher, R. J. (1995) Synthesis and characterization of N-acetyl-L-cysteine S-conjugates of butadiene monoxide and their detection and quantitation in urine of rats and mice given butadiene monoxide. Chem. Res. Toxicol. 8, 68-76.
22. Carmella, S. G., Han, S., Fristad, A., Yang, Y., and Hecht, S. S. (2003) Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol. Biomarkers Prev. 12, 1257-1261. (Pubitemid 37499454)
23. Carmella, S. G., Le, K., and Hecht, S. S. (2004) Improved method for determination of 1-hydroxypyrene in human urine. Cancer Epidemiol. Biomarkers Prev. 13, 1261-1264. (Pubitemid 38917919)
24. Sabourin, P. J., Burka, L. T., Bechtold, W. E., Dahl, A. R., Hoover, M. D., Chang, I. Y., and Henderson, R. F. (1992) Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl) butane, a novel metabolite of butadiene. Carcinogenesis 13, 1633-1638.
25. Nauhaus, S. K., Fennell, T. R., Asgharian, B., Bond, J. A., and Sumner, S. C. (1996) Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene. Chem. Res. Toxicol. 9, 764-773. (Pubitemid 26181627)
26. Richardson, K. A., Peters, M. M., Wong, B. A., Megens, R. H., van Elburg, P. A., Booth, E. D., Boogaard, P. J., Bond, J. A., Medinsky, M. A., Watson, W. P., and van Sittert, N. J. (1999) Quantitative and qualitative differences in the metabolism of 14C-1,3-butadiene in rats and mice: relevance to cancer susceptibility. Toxicol. Sci. 49, 186-201. (Pubitemid 29300405)
27. Sprague, C. L., and Elfarra, A. A. (2004) Mercapturic acid urinary metabolites of 3-butene-1,2-diol as in vivo evidence for the formation of hydroxymethylvinyl ketone in mice and rats. Chem. Res. Toxicol. 17, 819-826. (Pubitemid 38856343)
28. Bechtold, W. E., Strunk, M. R., Chang, I. Y., Ward, J. B., Jr., and Henderson, R. F. (1994) Species differences in urinary butadiene metabolites: comparisons of metabolite ratios between mice, rats, and humans. Toxicol. Appl. Pharmacol. 127, 44-49. (Pubitemid 24248632)
29. Fustinoni, S., Soleo, L., Warholm, M., Begemann, P., Rannug, A., Neumann, H. G., Swenberg, J. A., Vimercati, L., and Colombi, A. (2002) Influence of metabolic genotypes on biomarkers of exposure to 1,3- butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 11, 1082-1090. (Pubitemid 35192661)
30. van Sittert, N. J., Megens, H. J., Watson, W. P., and Boogaard, P. J. (2000) Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment. Toxicol. Sci. 56, 189-202. (Pubitemid 30441479)
31. Boogaard, P. J., van Sittert, N. J., and Megens, H. J. (2001) Urinary metabolites and haemoglobin adducts as biomarkers of exposure to 1,3-butadiene: a basis for 1,3-butadiene cancer risk assessment. Chem.-Biol. Interact. 135-136.
32. Urban, M., Gilch, G., Schepers, G., van Miert, E., and Scherer, G. (2003) Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. J. Chromatogr., B 796, 131-140. (Pubitemid 38352717)
33. Fustinoni, S., Perbellini, L., Soleo, L., Manno, M., and Foa, V. (2004) Biological monitoring in occupational exposure to low levels of 1,3-butadiene. Toxicol. Lett. 149, 353-360. (Pubitemid 38469853)
34. McDonald, J. D., Bechtold, W. E., Krone, J. R., Blackwell, W. B., Kracko, D. A., and Henderson, R. F. (2004) Analysis of butadiene urinary metabolites by liquid chromatography-triple quadrupole mass spectrometry. J. Anal. Toxicol. 28, 168-173. (Pubitemid 38456374)
35. Albertini, R. J., Sram, R. J., Vacek, P. M., Lynch, J., Wright, M., Nicklas, J. A., Boogaard, P. J., Henderson, R. F., Swenberg, J. A., Tates, A. D., and Ward, J. B., Jr. (2001) Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem.-Biol. Interact. 135-136, 429-453.
36. Hayes, R. B., Zhang, L., Yin, S., Swenberg, J. A., Xi, L., Wiencke, J., Bechtold, W. E., Yao, M., Rothman, N., Haas, R., O'Neill, J. P., Zhang, D., Wiemels, J., Dosemeci, M., Li, G., and Smith, M. T. (2000) Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 21, 55-62. (Pubitemid 30064144)
37. Albertini, R. J., Sram, R. J., Vacek, P. M., Lynch, J., Nicklas, J. A., van Sittert, N. J., Boogaard, P. J., Henderson, R. F., Swenberg, J. A., Tates, A. D., Ward, J. B., Jr., Wright, M., Ammenheuser, M. M., Binkova, B., Blackwell, W., de Zwart, F. A., Krako, D., Krone, J., Megens, H., Musilova, P., Rajska, G., Ranasinghe, A., Rosenblatt, J. I., Rossner, P., Rubes, J., Sullivan, L., Upton, P., and Zwinderman, A. H. (2003) Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study. Res. Rep. Health Eff. Inst. 1-141.
38. Sarkar, M., Kapur, S., Frost-Pineda, K., Feng, S., Wang, J., Liang, Q., and Roethig, H. (2008) Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies. Nicotine Tob. Res. 10, 1761-1772.
39. Parent, R. A., Paust, D. E., Schrimpf, M. K., Talaat, R. E., Doane, R. A., Caravello, H. E., Lee, S. J., and Sharp, D. E. (1998) Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. II. Identification of urinary and fecal metabolites. Toxicol. Sci. 43, 110-120. (Pubitemid 28363384)
40. Gray, J. M., and Barnsley, E. A. (1971) The metabolism of crotyl phosphate, crotyl alcohol and crotonaldehyde. Xenobiotica 1, 55-67.
41. Mascher, D. G., Mascher, H. J., Scherer, G., and Schmid, E. R. (2001) High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine. J. Chromatogr., B 750, 163-169. (Pubitemid 33648341)
42. Mendes, P., Kapur, S., Wang, J., Feng, S., and Roethig, H. (2008) A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes. Regul. Toxicol. Pharmacol. 51, 295-305.
43. Roethig, H. J., Feng, S., Liang, Q., Liu, J., Rees, W. A., and Zedler, B. K. (2008) A 12-month, randomized, controlled study to evaluate exposure and cardiovascular risk factors in adult smokers switching from conventional cigarettes to a second-generation electrically heated cigarette smoking system. J. Clin. Pharmacol. 48, 580-591.
44. Henderson, A. P., Barnes, M. L., Bleasdale, C., Cameron, R., Clegg, W., Heath, S. L., Lindstrom, A. B., Rappaport, S. M., Waidyanatha, S., Watson, W. P., and Golding, B. T. (2005) Reactions of benzene oxide with thiols including glutathione. Chem. Res. Toxicol. 18, 265-270. (Pubitemid 40256245)
45. Qu, Q., Melikian, A. A., Li, G., Shore, R., Chen, L., Cohen, B., Yin, S., Kagan, M. R., Li, H., Meng, M., Jin, X., Winnik, W., Li, Y., Mu, R., and Li, K. (2000) Validation of biomarkers in humans exposed to benzene: urine metabolites. Am. J. Ind. Med. 37, 522-531. (Pubitemid 30193755)
46. Feng, S., Roethig, H. J., Liang, Q., Kinser, R., Jin, Y., Scherer, G., Urban, M., Engl, J., and Riedel, K. (2006) Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3 methyladenine, 3-ethyladenine, 8-hydroxy-2′-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke. Biomarkers 11, 28-52. (Pubitemid 43250550)
47. Kim, S., Vermeulen, R., Waidyanatha, S., Johnson, B. A., Lan, Q., Rothman, N., Smith, M. T., Zhang, L., Li, G., Shen, M., Yin, S., and Rappaport, S. M. (2006) Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. Carcinogenesis 27, 772-781.
48. Qu, Q., Cohen, B. S., Shore, R., Chen, L. C., Li, G., Jin, X., Melikian, A. A., Yin, S., Yan, H., Xu, B., Li, Y., Mu, R., Zhang, X., and Li, K. (2003) Benzene exposure measurement in shoe and glue manufacturing: a study to validate biomarkers. Appl. Occup. Environ. Hyg. 18, 988-998. (Pubitemid 38031118)
49. van Sittert, N. J., Boogaard, P. J., and Beulink, G. D. (1993) Application of the urinary S-phenylmercapturic acid test as a biomarker for low levels of exposure to benzene in industry. Br. J. Ind. Med. 50, 460-469. (Pubitemid 23159624)
50. Barbieri, A., Sabatini, L., Accorsi, A., Roda, A., and Violante, F. S. (2004) Simultaneous determination of t,t-muconic, S-phenylmercapturic and S-benzylmercapturic acids in urine by a rapid and sensitive liquid chromatography/electrospray tandem mass spectrometry method. Rapid Commun. Mass Spectrom. 18, 1983-1988. (Pubitemid 39079176)
51. Maestri, L., Negri, S., Ferrari, M., Ghittori, S., and Imbriani, M. (2005) Determination of urinary S-phenylmercapturic acid, a specific metabolite of benzene, by liquid chromatography/single quadrupole mass spectrometry. Rapid Commun. Mass Spectrom. 19, 1139-1144. (Pubitemid 40654040)
52. Lin, L. C., Shih, J. F., Shih, T. S., Li, Y. J., and Liao, P. C. (2004) An electrospray ionization tandem mass spectrometry based system with an online dual-loop cleanup device for simultaneous quantitation of urinary benzene exposure biomarkers trans,trans-muconic acid and S-phenylmercapturic acid. Rapid Commun. Mass Spectrom. 18, 2743-2752. (Pubitemid 39546006)
53. Lin, L. C., Tyan, Y. C., Shih, T. S., Chang, Y. C., and Liao, P. C. (2004) Development and validation of an isotope-dilution electrospray ionization tandem mass spectrometry method with an on-line sample clean-up device for the quantitative analysis of the benzene exposure biomarker S-phenylmercapturic acid in human urine. Rapid Commun. Mass Spectrom. 18, 1310-1316. (Pubitemid 38843153)
54. Schettgen, T., Musiol, A., Alt, A., and Kraus, T. (2008) Fast determination of urinary S-phenylmercapturic acid (S-PMA) and S-benzylmercapturic acid (S-BMA) by column-switching liquid chromatography- tandem mass spectrometry. J. Chromatogr., B 863, 283-292.
55. Sabatini, L., Barbieri, A., Indiveri, P., Mattioli, S., and Violante, F. S. (2008) Validation of an HPLC-MS/MS method for the simultaneous determination of phenylmercapturic acid, benzylmercapturic acid and o-methylbenzyl mercapturic acid in urine as biomarkers of exposure to benzene, toluene and xylenes. J. Chromatogr., B 863, 115-122.
56. Paci, E., Pigini, D., Cialdella, A. M., Faranda, P., and Tranfo, G. (2007) Determination of free and total S-phenylmercapturic acid by HPLC/MS/MS in the biological monitoring of benzene exposure. Biomarkers 12, 111-122. (Pubitemid 47161393)
57. Gerin, M., and Tardif, R. (1986) Urinary N-acetyl-S-2-hydroxyethyl-L- cysteine in rats as biological indicator of ethylene oxide exposure. Fundam. Appl. Toxicol. 7, 419-423. (Pubitemid 16005787)
58. Tardif, R., Goyal, R., Brodeur, J., and Gerin, M. (1987) Species differences in the urinary disposition of some metabolites of ethylene oxide. Fundam. Appl. Toxicol. 9, 448-453.
59. Popp, W., Vahrenholz, C., Przygoda, H., Brauksiepe, A., Goch, S., Muller, G., Schell, C., and Norpoth, K. (1994) DNA-protein cross-links and sister chromatid exchange frequencies in lymphocytes and hydroxyethyl mercapturic acid in urine of ethylene oxide-exposed hospital workers. Int. Arch. Occup. Environ. Health 66, 325-332.
60. Barr, D. B., and Ashley, D. L. (1998) A rapid, sensitive method for the quantitation of N-acetyl-S-(2-hydroxyethyl)-L-cysteine in human urine using isotope-dilution HPLC-MS-MS. J. Anal. Toxicol. 22, 96-104. (Pubitemid 28128956)
61. Jacob, J., and Seidel, A. (2002) Biomonitoring of polycyclic aromatic hydrocarbons in human urine. J. Chromatogr., B 778, 31-47.
62. Hansen, A. M., Mathiesen, L., Pedersen, M., and Knudsen, L. E. (2008) Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies- a review. Int. J. Hyg. Environ. Health 211, 471-503.
63. Hecht, S. S., Murphy, S. E., Carmella, S. G., Li, S., Jensen, J., Le, C., Joseph, A. M., and Hatsukami, D. K. (2005) Similar uptake of lung carcinogens by smokers of regular, light, and ultra-light cigarettes. Cancer Epidemiol. Biomarkers Prev. 14, 693-698. (Pubitemid 40489216)
64. Hatsukami, D. K., Lemmonds, C., Zhang, Y., Murphy, S. E., Le, C., Carmella, S. G., and Hecht, S. S. (2004) Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products. J. Natl. Cancer Inst. 96, 844-852.
65. Hecht, S. S., Carmella, S. G., Chen, M., Koch, J. F. D., Miller, A. T., Murphy, S. E., Jensen, J. A., Zimmerman, C. L., and Hatsukami, D. K. (1999) Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. 59, 590-596. (Pubitemid 29076055)
66. Hecht, S. S. (2008) Progress and challenges in selected areas of tobacco carcinogenesis. Chem. Res. Toxicol. 21, 160-171.